Compare Peptides

Select any two compounds for a side-by-side comparison of mechanism, uses, risks, and FDA regulatory status.

Popular comparisons

Kisspeptin

Kisspeptin-54, Kisspeptin-10

Investigational
Hormonal & Reproductive

Oxytocin

Pitocin, Syntocinon

FDA Approved
Neurological & Hormonal
Overview

A neuropeptide that acts as the master regulator of the reproductive hormone axis. Kisspeptin neurons in the hypothalamus control the release of GnRH (gonadotropin-releasing hormone), which in turn drives LH and FSH production. Increasingly studied for fertility treatment, hypogonadism, and as a diagnostic tool for reproductive disorders. Also being explored for its role in emotional and sexual brain processing.

A naturally occurring nonapeptide produced in the hypothalamus and released by the pituitary gland. Known as the 'bonding hormone' for its role in social bonding, trust, and attachment. Also has established medical uses in obstetrics. Growing interest in intranasal oxytocin for social anxiety, autism spectrum disorder, and relationship enhancement.

Mechanism of Action

Binds to the KISS1R (GPR54) receptor on GnRH neurons in the hypothalamus, triggering GnRH release. This stimulates the anterior pituitary to release LH and FSH, which drive testosterone production in males and ovulation in females. Kisspeptin is the upstream 'gatekeeper' of the entire HPG axis.

Binds to oxytocin receptors throughout the brain and body. In the brain, modulates the limbic system to reduce fear and increase trust and social engagement. Peripherally, stimulates uterine contractions (obstetric use) and milk ejection. Intranasal delivery allows direct access to the brain via the olfactory pathway.

Common Uses
  • Fertility treatment (investigational)
  • Hypogonadism evaluation
  • IVF protocols (as GnRH trigger alternative)
  • Reproductive endocrinology research
  • Libido and sexual function research
  • Social anxiety and social bonding
  • Autism spectrum disorder support (investigational)
  • Relationship and intimacy enhancement
  • Postpartum bonding
  • Labor induction (FDA-approved obstetric use)
Known Risks
  • Injection site discomfort
  • Headache and flushing
  • Potential for ovarian hyperstimulation in women
  • Short half-life requires frequent dosing or infusion
  • Limited long-term safety data
  • Potential for emotional dependency with frequent use
  • May amplify negative social emotions as well as positive ones
  • Headaches and nausea
  • Intranasal use has limited long-term safety data
  • Contraindicated in certain obstetric situations
Regulatory Status
Investigational

Not FDA-approved. Active clinical trials at Imperial College London and other institutions for fertility applications. Being studied as a safer alternative to hCG triggers in IVF (lower risk of ovarian hyperstimulation syndrome). No US-approved formulation exists.

FDA Approved

FDA-approved as Pitocin for obstetric use (labor induction, postpartum hemorrhage). Intranasal oxytocin for psychiatric and social indications is investigational — not FDA-approved for these uses. Available through compounding pharmacies with a prescription for off-label intranasal use.

This comparison is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide therapy.